logo

Novocure (NVCR)



Trade NVCR now with
  Date
  Headline
1/5/2023 8:09:53 AM Zai Lab And Novocure Announce Pivotal LUNAR Study In NSCLC Meets Primary Overall Survival Endpoint
12/7/2021 4:20:57 PM Novocure Signs Agreement To Acquire And Construct Building In Downtown Portsmouth, New Hampshire
10/4/2021 7:50:06 AM Novocure, Zai Lab Announce Last Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Plus Chemotherapy
4/9/2021 7:34:02 AM Novocure Announces 26 Presentations At American Association For Cancer Research Annual Meeting 2021
7/26/2019 8:36:26 AM Wedbush Is Cutting NovoCure (NVCR) FY20 Rev. Estimate To 484.6 M From 1601 M
7/26/2019 8:36:01 AM Wedbush Is Lowering NovoCure (NVCR) Q4 20 Rev. Estimate To 132.8 M From 1163 M
7/26/2019 8:35:49 AM Wedbush Is Lowering NovoCure (NVCR) Q3 20 Rev. Estimate To 124.8 M From 866.4 M
7/26/2019 8:35:24 AM Wedbush Is Cutting NovoCure (NVCR) Q2 20 Rev. Estimate To 118.8 M From 609.0 M
7/26/2019 8:35:11 AM Wedbush Is Lowering NovoCure (NVCR) Q1 20 Rev. Estimate To 108.2 M From 492.1 M
7/26/2019 8:34:51 AM Wedbush Is Increasing NovoCure (NVCR) FY19 Rev. Estimate To 351.1 M From 348.3 M
7/26/2019 8:34:40 AM Wedbush Is Cutting NovoCure (NVCR) Q4 19 Rev. Estimate To 99.9 M From 101.0 M
7/26/2019 8:34:29 AM Wedbush Is Lowering NovoCure (NVCR) Q3 19 Rev. Estimate To 91.2 M From 93.4 M
7/26/2019 8:34:04 AM Wedbush Is Cutting NovoCure (NVCR) FY20 Estimate To 0.63 From 8.09
7/26/2019 8:33:53 AM Wedbush Is Lowering NovoCure (NVCR) Q4 20 Estimate To 0.20 From 4.91
7/26/2019 8:33:41 AM Wedbush Is Lowering NovoCure (NVCR) Q3 20 Estimate To 0.17 From 2.95
7/26/2019 8:33:28 AM Wedbush Is Lowering NovoCure (NVCR) Q2 20 Estimate To 0.15 From 1.21
7/26/2019 8:33:16 AM Wedbush Is Cutting NovoCure (NVCR) Q1 20 Estimate To 0.10 From 0.63